rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    EVGN
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Evogene Schedules Third Quarter 2026 Financial Results Release
      Nov 5Yahoo FinanceEVGN
      Evogene Announces Acute Graft-Versus-Host Disease (aGVHD) as the Target Indication for Its Internal AI-Driven Drug Discovery Program

      Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering computational chemistry company specializing in AI-driven generative design of small molecules for the pharmaceutical and agricultural industries, today announced acute graft-versus-host disease (aGVHD) as the target indication for its internal drug discovery program.

      Oct 28Yahoo FinanceEVGN
      Evogene to Participate in Upcoming BIO-Europe in Germany and Drug Discovery Chemistry Europe in Spain

      Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), pioneering company in computational chemistry specializing in AI-based generative design of small molecules for the pharmaceutical and agricultural industries, today announced its participation in two upcoming industry conferences in Europe: BIO-Europe, to be held November 9-11, 2026, in Cologne, Germany, and Drug Discovery Chemistry Europe, to be held November 10-12, 2026, in Barcelona, Spain.

      Oct 26Yahoo FinanceEVGN
      Evogene to Participate in U.S. East Coast AI Drug Discovery Roadshow Organized by the Israel Export Institute and TradeIL
      Oct 20Yahoo FinanceEVGN
      Evogene Strikes Governance Deal With Pure Capital Group, Reconstitutes Board

      Detailed price information for Evogene Ltd Ord (EVGN-Q) from The Globe and Mail including charting and trades.

      Oct 7The Globe and MailEVGN
      Evogene reaches agreement with Pure Capital Group on board changes
      Oct 6Investing.comEVGN
      Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors
      Oct 6Yahoo FinanceEVGN
      Evogene receives 180-day extension for Nasdaq compliance
      Sep 30Investing.comEVGN
      Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance
      Sep 30MorningstarEVGN
      12 Health Care Stocks Moving In Tuesday's After-Market Session - Evogene (NASDAQ:EVGN), AIxCrypto Hldgs (

      Gainers Evogene (NASDAQ:EVGN) shares increased by 75.0% to $0.72 during Tuesday's after-market session. The company's market cap stands at $4.5 million. AIxCrypto Hldgs (NASDAQ:AIXC) stock moved upwards by

      Sep 29BenzingaEVGNRLMD
      Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward

      Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneer in computational chemistry specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, today responded to the latest communication from dissident shareholders L.I.A. Pure Capital and Invest-Pro.

      Aug 31Yahoo FinanceEVGN
      Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly Qualified Director Nominees
      Aug 25MorningstarEVGN
      Evogene (EVGN) Q2 2026 Earnings Call Transcript

      Motley Fool Press Release.

      Aug 25The Globe and MailEVGN
      ISS and Glass Lewis back Evogene board nominees ahead of vote
      Aug 25Investing.comEVGN

      This is the newest page. Registered accounts read further back.